Article Details

Landmark brain cancer vaccine passes first phase of human trials

Retrieved on: 2021-03-24 23:56:43

Tags for this article:

Click the tags to see associated articles and topics

Landmark brain cancer vaccine passes first phase of human trials. View article details on hiswai:

Excerpt

Looking at immune responses the researchers found 93 percent of patients displayed an effective response to the vaccine. Immune T cells specifically ...

Article found on: newatlas.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up